Tim Schlidt is Funding a New Paradigm in Wellbeing
Manage episode 344590802 series 3342868
On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo.
Palo Santo is a leading therapeutics investment fund dedicated to increasing the global supply of clinically effective and accessible healthcare solutions.
Tim is a Co-Founder and Partner of the fund, sits on the Board of many psychedelics companies, and recently closed a $50 million fund.
Tune in to learn more about Palo Santo's investment thesis, portfolio, and goals for the future of psychedelic-assisted therapies and beyond.
50 episodes